...
coll-img

Collegium Pharmaceutical Inc, Common Stock

COLL

NSQ

$29.7

-$0.74

(-2.43%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$968.15M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
12.8291
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.20M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.95
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$28.97 L
$42.29 H
$29.7

About Collegium Pharmaceutical Inc, Common Stock

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameCOLLSectorS&P500
1-Week Return-1.3%-2.12%-3%
1-Month Return-1%-3.42%-0.73%
3-Month Return-23.98%-11.13%2.87%
6-Month Return-5.95%-5.74%7.17%
1-Year Return-0.44%3.97%25.31%
3-Year Return57.48%1.05%28.38%
5-Year Return50.91%34.37%81.89%
10-Year Return141.66%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue296.70M310.02M276.87M463.93M566.77M[{"date":"2019-12-31","value":52.35,"profit":true},{"date":"2020-12-31","value":54.7,"profit":true},{"date":"2021-12-31","value":48.85,"profit":true},{"date":"2022-12-31","value":81.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue193.66M130.18M126.25M254.44M240.60M[{"date":"2019-12-31","value":76.11,"profit":true},{"date":"2020-12-31","value":51.16,"profit":true},{"date":"2021-12-31","value":49.62,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.56,"profit":true}]
Gross Profit103.04M179.84M150.62M209.49M326.17M[{"date":"2019-12-31","value":31.59,"profit":true},{"date":"2020-12-31","value":55.14,"profit":true},{"date":"2021-12-31","value":46.18,"profit":true},{"date":"2022-12-31","value":64.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin34.73%58.01%54.40%45.15%57.55%[{"date":"2019-12-31","value":59.87,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":93.78,"profit":true},{"date":"2022-12-31","value":77.84,"profit":true},{"date":"2023-12-31","value":99.21,"profit":true}]
Operating Expenses126.79M123.60M128.41M176.17M159.21M[{"date":"2019-12-31","value":71.97,"profit":true},{"date":"2020-12-31","value":70.16,"profit":true},{"date":"2021-12-31","value":72.89,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.37,"profit":true}]
Operating Income(23.75M)(5.09M)(46.70M)(104.57M)166.96M[{"date":"2019-12-31","value":-14.22,"profit":false},{"date":"2020-12-31","value":-3.05,"profit":false},{"date":"2021-12-31","value":-27.97,"profit":false},{"date":"2022-12-31","value":-62.63,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense2.05M(57.30M)(42.00M)(124.33M)(158.95M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-2792.4,"profit":false},{"date":"2021-12-31","value":-2046.98,"profit":false},{"date":"2022-12-31","value":-6059.06,"profit":false},{"date":"2023-12-31","value":-7746.2,"profit":false}]
Pre-Tax Income(22.72M)27.58M(3.37M)(28.85M)75.73M[{"date":"2019-12-31","value":-30,"profit":false},{"date":"2020-12-31","value":36.42,"profit":true},{"date":"2021-12-31","value":-4.46,"profit":false},{"date":"2022-12-31","value":-38.09,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes(14.57M)830.00K(74.89M)(3.85M)27.58M[{"date":"2019-12-31","value":-52.85,"profit":false},{"date":"2020-12-31","value":3.01,"profit":true},{"date":"2021-12-31","value":-271.56,"profit":false},{"date":"2022-12-31","value":-13.94,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(8.15M)26.75M71.52M(25.00M)48.16M[{"date":"2019-12-31","value":-11.39,"profit":false},{"date":"2020-12-31","value":37.41,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-34.96,"profit":false},{"date":"2023-12-31","value":67.33,"profit":true}]
Income From Continuous Operations(22.72M)26.75M71.52M(25.00M)48.16M[{"date":"2019-12-31","value":-31.77,"profit":false},{"date":"2020-12-31","value":37.41,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-34.96,"profit":false},{"date":"2023-12-31","value":67.33,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(8.15M)26.75M71.52M(25.00M)48.16M[{"date":"2019-12-31","value":-11.39,"profit":false},{"date":"2020-12-31","value":37.41,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-34.96,"profit":false},{"date":"2023-12-31","value":67.33,"profit":true}]
EPS (Diluted)(0.68)0.760.390.561.18[{"date":"2019-12-31","value":-57.63,"profit":false},{"date":"2020-12-31","value":64.41,"profit":true},{"date":"2021-12-31","value":33.05,"profit":true},{"date":"2022-12-31","value":47.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

COLL
Cash Ratio 0.26
Current Ratio 0.97
Quick Ratio 0.88

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

COLL
ROA (LTM) 9.68%
ROE (LTM) 42.89%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

COLL
Debt Ratio Lower is generally better. Negative is bad. 0.86
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.14

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

COLL
Trailing PE 13.01
Forward PE 4.80
P/S (TTM) 1.64
P/B 4.19
Price/FCF NM
EV/R 2.90
EV/Ebitda 5.01
PEG NM

FAQs

What is Collegium Pharmaceutical Inc share price today?

Collegium Pharmaceutical Inc (COLL) share price today is $29.7

Can Indians buy Collegium Pharmaceutical Inc shares?

Yes, Indians can buy shares of Collegium Pharmaceutical Inc (COLL) on Vested. To buy Collegium Pharmaceutical Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in COLL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Collegium Pharmaceutical Inc be purchased?

Yes, you can purchase fractional shares of Collegium Pharmaceutical Inc (COLL) via the Vested app. You can start investing in Collegium Pharmaceutical Inc (COLL) with a minimum investment of $1.

How to invest in Collegium Pharmaceutical Inc shares from India?

You can invest in shares of Collegium Pharmaceutical Inc (COLL) via Vested in three simple steps:

  • Click on Sign Up or Invest in COLL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Collegium Pharmaceutical Inc shares
What is Collegium Pharmaceutical Inc 52-week high and low stock price?

The 52-week high price of Collegium Pharmaceutical Inc (COLL) is $42.29. The 52-week low price of Collegium Pharmaceutical Inc (COLL) is $28.97.

What is Collegium Pharmaceutical Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Collegium Pharmaceutical Inc (COLL) is 12.8291

What is Collegium Pharmaceutical Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Collegium Pharmaceutical Inc (COLL) is 4.19

What is Collegium Pharmaceutical Inc dividend yield?

The dividend yield of Collegium Pharmaceutical Inc (COLL) is 0.00%

What is the Market Cap of Collegium Pharmaceutical Inc?

The market capitalization of Collegium Pharmaceutical Inc (COLL) is $968.15M

What is Collegium Pharmaceutical Inc’s stock symbol?

The stock symbol (or ticker) of Collegium Pharmaceutical Inc is COLL

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top